Show simple item record

dc.contributor.advisorO'Connor, Mary-Francesen
dc.contributor.authorLong, Emily Nicole
dc.creatorLong, Emily Nicoleen
dc.date.accessioned2017-07-28T21:40:40Z
dc.date.available2017-07-28T21:40:40Z
dc.date.issued2017
dc.identifier.citationLong, Emily Nicole. (2017). Exploratory Behavioral and Neural Effects of Inflammation-Induced Sickness Behavior (Bachelor's thesis, University of Arizona, Tucson, USA).
dc.identifier.urihttp://hdl.handle.net/10150/625042
dc.description.abstractSickness behavior entails behavioral changes such as anxiety or fatigue due to increased circulatory proinflammatory cytokine (IL-6) levels. By crossing the blood-brain barrier, IL-6 induces widespread but poorly understood neurological changes that potentially shift the body's energetic prioritization toward immune recovery. The present study focuses on identifying the mechanisms and behavioral consequences of human sickness behavior on exploration. Sickness behavior was hypothesized to demonstrate a decrease in natural human exploration by dopaminergic mechanisms. We assessed this behavioral phenomenon in participants' exploration of a novel virtual open-field test and a gambling task. Upon receiving the vaccine, participants reported decreased attentional impulsivity on the BIS-11 scale and decrease perceived stress. Participants traversed less and paused more in the virtual-reality open-field test when vaccinated, both of which were mediated by immune reactivity as measured by change in IL-6 levels. These findings support goals of sickness behavior: less curiosity to explore virtual-reality is less cognitively expensive, so energy otherwise invested in pursuing curiosities can focus on immune recovery instead. Further studies on how inflammation changes behavior and neurological regions implicated could improve patient quality of life through better diagnosis and management of inflammation-induced side effects such as depression.
dc.language.isoen_USen
dc.publisherThe University of Arizona.en
dc.rightsCopyright © is held by the author. Digital access to this material is made possible by the University Libraries, University of Arizona. Further transmission, reproduction or presentation (such as public display or performance) of protected items is prohibited except with permission of the author.en
dc.rights.urihttp://rightsstatements.org/vocab/InC/1.0/
dc.titleExploratory Behavioral and Neural Effects of Inflammation-Induced Sickness Behavioren_US
dc.typetexten
dc.typeElectronic Thesisen
thesis.degree.grantorUniversity of Arizonaen
thesis.degree.levelbachelorsen
thesis.degree.disciplineHonors Collegeen
thesis.degree.disciplineNeuroscience and Cognitive Scienceen
thesis.degree.nameB.S.en
refterms.dateFOA2018-06-24T17:52:10Z
html.description.abstractSickness behavior entails behavioral changes such as anxiety or fatigue due to increased circulatory proinflammatory cytokine (IL-6) levels. By crossing the blood-brain barrier, IL-6 induces widespread but poorly understood neurological changes that potentially shift the body's energetic prioritization toward immune recovery. The present study focuses on identifying the mechanisms and behavioral consequences of human sickness behavior on exploration. Sickness behavior was hypothesized to demonstrate a decrease in natural human exploration by dopaminergic mechanisms. We assessed this behavioral phenomenon in participants' exploration of a novel virtual open-field test and a gambling task. Upon receiving the vaccine, participants reported decreased attentional impulsivity on the BIS-11 scale and decrease perceived stress. Participants traversed less and paused more in the virtual-reality open-field test when vaccinated, both of which were mediated by immune reactivity as measured by change in IL-6 levels. These findings support goals of sickness behavior: less curiosity to explore virtual-reality is less cognitively expensive, so energy otherwise invested in pursuing curiosities can focus on immune recovery instead. Further studies on how inflammation changes behavior and neurological regions implicated could improve patient quality of life through better diagnosis and management of inflammation-induced side effects such as depression.


Files in this item

Thumbnail
Name:
azu_etd_hr_2017_0117_sip1_m.pdf
Size:
3.419Mb
Format:
PDF

This item appears in the following Collection(s)

Show simple item record